SCHEMBL21967445

SCHEMBL21967445

Fc1ccc(Nc2nc(Br)nc3c2ncn3C2CCCCO2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 10/20 0.64
YTHDC1 Q96MU7 1/20 0.52
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP2C19 P33261 1/20 0.45
CDK1 P06493 2/20 0.42
TP53 P04637 1/20 0.40
CYP2C9 P11712 1/20 0.40
NFKB1 P19838 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
APEX1 P27695 1/20 0.40
PI4KA P42356 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
ADCY1 Q08828 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21967658 0.97 FLT3 (0.59) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967885 0.92 FLT3 (0.74) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967753 0.91 FLT3 (0.65) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967507 0.90 FLT3 (0.64) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967409 0.90 FLT3 (0.64) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967147 0.90 FLT3 (0.60) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967315 0.89 FLT3 (0.59) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967579 0.89 FLT3 (0.69) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967784 0.88 FLT3 (0.58) FLT3YTHDC1NPC1RAB9ASMN1; SMN2
SCHEMBL21967806 0.88 FLT3 (0.58) FLT3YTHDC1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662194-B2 Substituted 6-anilino-9-heterocyclylpurine derivatives for inhibition of plant stress UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2020-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662194-B2 Substituted 6-anilino-9-heterocyclylpurine derivatives for inhibition of plant stress TPMT, MTAP, ATIC FLT3 2877/4885YTHDC1 384/4885NPC1 3926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.